Document is current
Any future updates will be listed below
-
Authors
Narang, Ravi K.
Gamble, Greg G.
Khaw, Kay-Tee
Camargo, Carlos A. Jr
Sluyter, John D.
Scragg, Robert K. R.
Reid, Ian R.
-
Funding
Funding for this research was provided by:
Health Research Council of New Zealand (10/400)
- License Information
-
More Information
Article History
Received: 3 May 2020
Accepted: 20 October 2020
First Online: 31 October 2020
Compliance with ethical standards
:
: I.R.R. receives grant support, lecture fees, and consulting fees from Amgen and Merck, consulting fees from Novartis, and lecture fees and consulting fees from Eli Lilly. None of the other authors have competing interests.
: Ethics approval for the ViDA study was granted by the Multiregion Ethics Committee, Wellington (MEC/09/08/082). All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.
: Not applicable.
: Informed consent was obtained from all individual participants included in the study.
: Not applicable.
